Clinical Trial Update: Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease [Phase 3]

View source ↗

Summary

This clinical trial update reports efficacy and safety results from a Phase 3 study of adalimumab in pediatric patients with moderate to severe Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-08-04